Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,943 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Modeling epidemics dynamics on heterogenous networks.
Ben-Zion Y, Cohen Y, Shnerb NM. Ben-Zion Y, et al. Among authors: cohen y. J Theor Biol. 2010 May 21;264(2):197-204. doi: 10.1016/j.jtbi.2010.01.029. Epub 2010 Feb 1. J Theor Biol. 2010. PMID: 20117115
Talquetamab plus Teclistamab in Relapsed or Refractory Multiple Myeloma.
Cohen YC, Magen H, Gatt M, Sebag M, Kim K, Min CK, Ocio EM, Yoon SS, Chu MP, Rodríguez-Otero P, Avivi I, Quijano Cardé NA, Kumar A, Krevvata M, Peterson MR, Di Scala L, Scott E, Hilder B, Vanak J, Banerjee A, Oriol A, Morillo D, Mateos MV; RedirecTT-1 Investigators and Study Group. Cohen YC, et al. N Engl J Med. 2025 Jan 9;392(2):138-149. doi: 10.1056/NEJMoa2406536. N Engl J Med. 2025. PMID: 39778168 Clinical Trial.
Engineering of the genetic code.
Cohen Y, Alfonta L. Cohen Y, et al. Curr Opin Biotechnol. 2024 Dec 28;91:103245. doi: 10.1016/j.copbio.2024.103245. Online ahead of print. Curr Opin Biotechnol. 2024. PMID: 39733656 Review.
Efficacy and Safety of Anti-B-Cell Maturation Antigen Chimeric Antigen Receptor T-Cell for the Treatment of Relapsed and Refractory AL Amyloidosis.
Lebel E, Asherie N, Kfir-Erenfeld S, Grisariu S, Avni B, Elias S, Assayag M, Dubnikov-Sharon T, Pick M, Alexander-Shani R, Bessig N, Herr S, Shehadeh A, Ishtay A, Pimienta S, Vainstein V, Zimran E, Cohen Y, Avivi I, Cohen C, Stepensky P, Gatt ME. Lebel E, et al. Among authors: cohen y. J Clin Oncol. 2024 Dec 9:JCO2402252. doi: 10.1200/JCO-24-02252. Online ahead of print. J Clin Oncol. 2024. PMID: 39653116
Efficacy and Safety of Daratumumab in Intermediate/High-risk Smoldering Multiple Myeloma: Final Analysis of CENTAURUS.
Landgren CO, Chari A, Cohen YC, Spencer A, Voorhees PM, Sandhu I, Jenner MW, Smith D, Cavo M, van de Donk NWCJ, Beksac M, Moreau P, Goldschmidt H, Vieyra D, Sha L, Li L, Rousseau E, Dennis RM, Carson R, Hofmeister CC. Landgren CO, et al. Among authors: cohen yc. Blood. 2024 Dec 9:blood.2024025897. doi: 10.1182/blood.2024025897. Online ahead of print. Blood. 2024. PMID: 39652826
1,943 results